Heller Kevin N. 4
4 · Jasper Therapeutics, Inc. · Filed Mar 23, 2022
Insider Transaction Report
Form 4
Heller Kevin N.
EVP, Research and Development
Transactions
- Award
Stock Option (right to buy)
2022-03-21+7,500→ 7,500 totalExercise: $3.54Exp: 2032-03-21→ Voting Common Stock (7,500 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on December 7, 2022, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.